ClaimsFiler, a FREE shareholder information service, reminds investors that they have only until October 24, 2017 to file lead plaintiff applications in a securities class action lawsuit against Dr. Reddy's Laboratories Ltd. (NYSE: RDY). Investor losses must relate to purchases of the Company's securities between June 17, 2015 and August 10, 2017. This action is pending in the United States District Court for the District of New Jersey.

Get Help

Dr. Reddy's investors should visit us at or call to speak to our claim center toll-free at (844) 367-9658.

About ClaimsFiler

ClaimsFiler has a single mission: to serve as the information source to help retail investors recover their share of billions of dollars from securities class action settlements. ClaimsFiler's team of experts monitor the securities class action landscape and cull information from a variety of sources to ensure comprehensive coverage across a broad range of financial instruments.

To learn more about ClaimsFiler, visit

View source version on

Copyright Business Wire 2010